In the past decade, there have been significant advances in the management of renal cancer with better ablation technologies, robotic nephron-sparing surgery, and a plethora of chemotherapy agents. Using carefully chosen cases and an MDT (multidisciplinary team) format, this webinar will update you on the latest evidence.
This webinar will review all relevant information from an MDT perspective about real cases. The cases have been selected to highlight some of the topical and controversial issues.
Topics to be covered:
Join in the conversation online using #RSMUrology
Follow us on Twitter: @RoySocMed and @RSMUrology
Standard pricing available until 11 February 2021.
| RSM Member | RSM Trainee | RSM Student |
|---|---|---|
| £12.00 | £9.00 | £6.00 |
| Non - Member | Trainee | Student |
|---|---|---|
| £20.00 | £15.00 | £10.00 |
Online
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place.
This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
